Merontos, Juvelyn A.
HRN: 25-22-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 1.5GM (VIAL)
11/19/2025
11/26/2025
IV
1.5g
Q8
Abscess With Cellulitis
Checking Initial Appropriateness